PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-03 (4)

Date Title Company
03-Feb-2023 Fate Therapeutics, Inc. (FATE) Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Fate Therapeutics, Inc. Businesswire